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Abstract
Clinical Vignette: A 64-year-old male with a history of essential tremor with bilateral thalamic ventralis intermedius deep brain stimulation implants had elevated
therapeutic impedance values despite normal lead integrity impedances and good response to stimulation.
Clinical Dilemma: Do elevated therapeutic impedance values indicate a sign of hardware malfunction? What are the guidelines to approach deep brain
stimulation hardware malfunction?
Clinical Solution: Lead integrity impedance values are a better evaluation of hardware integrity. The discrepancy between therapeutic and lead-integrity
impedance values can arise when using low voltage settings.
Gaps in Knowledge: There are no established guidelines for the management of possible hardware malfunction in deep brain stimulation. The recommended
approach is to distinguish between open and short circuit problems followed by an ‘‘inching’’ evaluation, assessing the structures from the implantable and
programmable generator to the intracranial leads. Constant-current devices will deliver a more stable stimulation but the effect of their adoption is still not clear.
Expert Commentary: This case emphasizes the need for clinicians to understand fundamental differences in lead integrity and therapeutic impedance while
utilizing a methodical approach in treating hardware malfunction. It highlights future avenues of investigation regarding the utility of constant current DBS technology.
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Clinical vignette
A 64-year-old male with a history of essential tremor that was
refractory to medication therapy had significant impairment and
disability in his activities of daily living, including eating and grooming.
He received bilateral thalamic ventralis intermedius (Vim) deep brain
stimulation (DBS) implants. The system included Medtronic 3387
(Minneapolis, MN) leads and the Activa PC 37601 implantable and
programmable generator (IPG). No surgical complications were
reported. He developed an immediate microlesion effect on the right
side of the body with a nearly month-long control of tremor prior to his
device activation. Post activation he improved beyond the microlesion
effect and he regained lost function in his activities of daily living. He
reported side effects of slurring of speech and tongue numbness when
the DBS was activated, and these were persistent at the setting that
maximally controlled tremors. A monopolar threshold survey for
benefits and side effects during programming revealed low thresholds
for sensory side effects on the left but not right Vim lead (Table 1).
Despite the narrow thresholds revealed at programming for the left
Vim DBS, a bipolar stimulation setting resulted in significant symptom
control without side effects. Postoperative lead location and mapping
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revealed that the left Vim was slightly lateral to the right Vim lead
(Figure 1).
Clinical dilemma
A discrepancy was observed between the measured lead integrity
impedances (LIIs) and the therapeutic impedances. The LII measured
at 3 V were within normal limits (Table 2). The therapeutic imped-
ances for the left Vim lead were recorded as abnormally high (Table 2).
Despite the high therapeutic impedance values, the patient had
a persistent positive clinical benefit with left Vim stimulation. The
bipolar configuration (2 as cathode and 3 as anode) provided an
optimal benefit to side effect ratio.
Table 1. Summary of the Side Effect Thresholds in the Monopolar Survey for the Bilateral Vim Performed 2 Months after left Vim
Implantation
Contact Tested Side Effect Threshold (V) Side Effect Noted
Left Vim
0 0.7 Tingling of right hand
1 0.7 Tingling of right fingertips
2 0.9 Tingling of right lip and first and second fingers
3 1.7 Tingling of right face and right hand with slurring of speech
Right Vim
8 1.5 Tingling of left hand
9 1.4 Tingling of left fingertips and lips
10 2 Tingling of left lip and slurring of speech
11 3 Tingling of lips and slurring of speech
Abbreviations: Vim, Thalamic Ventralis Intermedius.
Figure 1. Postoperative Lead Location Mapping. The dashed red line is the location of the deep brain stimulation lead based on comouted tomography–
magnetic resonance imaging fusion. The green structure the lead touches is the thalamus. The red structure beneath the thalamus is the subthalamic nucleus.
Coordinates for right thalamic ventralis intermedius (Vim), 3.9 mm posterior; 12.8 mm lateral; and 2.2 mm inferior to the midcommissural point. Coordinates for
left Vim, 5.7 mm posterior; 13.2 mm lateral; and 3.7 mm inferior to the midcommissural point.
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Several interesting questions arise from this clinical situation. What
is the difference between therapeutic impedance and LII? As the high
therapeutic impedance did not limit clinical benefit in this case, do elevated
therapeutic impedance values indicate a sign of hardware malfunction?
What are the guidelines to approach deep brain stimulation hardware
malfunction?
Clinical solution
To answer these questions, it is important to define a few terms first.
Impedance is a measure of resistance to the propagation of current
in an alternating current system.1
LII assesses the impedances at all the different contacts at pre-
determined stimulation parameters (set by the DBS manufacturer):
voltage 3 (LII6current), Ohm’s law.
LII measurements are surrogates of the electrical features of a DBS
system,2 assessing for hardware malfunction. Most LIIs usually fall in
the range of 500 to 1500 ohms.2 An increase in LII is frequently the
warning sign of an open electrical circuit (e.g., connector break) and a
drop is typically a sign indicating a short circuit.2,3 The LII measure-
ments available through the current IPGs have very good accuracy
(less than 4% error).4
The therapeutic impedance on the other hand assesses the impe-
dance of the system as programmed by the user and can be useful, for
example for battery usage and life estimation.1,5 The therapeutic
impedance is calculated by a relatively complex equation. This equa-
tion can result in overcompensation when low voltages are utilized and
it could reveal a ‘‘high’’ therapeutic impedance value.
In this case’s DBS system (Medtronic Activa PC), a high LII is
defined as a value above 40,000 ohms (when measured at 3 V), while a
high therapeutic impedance is defined as a value above 4,000 ohms. In
our case, the measured current associated with the optimal DBS
settings was low, 0.186–0.458 A (Table 2). A careful review of Table 2
however reveals that when set at a higher voltage (1.9 V), the
therapeutic impedance value (3154 ohms) gets closer to the LII. The
measured current also increased (0.622 A). The therapeutic impe-
dances are usually consistent with LII; however, this is highly
dependent on the stimulation parameters used. Lower voltages can
result in a discrepancy between the therapeutic impedance and LII as
noted in this case. The clinician programming a DBS patient should be
aware of what a ‘‘high’’ therapeutic impedance value may indicate, but
should also test the contact at higher voltage to confirm. It is impor-
tant for a practitioner to distinguish between LII and therapeutic
impedances.
The other interesting observation resides in the apparent disconnect
between the ‘‘high’’ measured therapeutic impedance and the persis-
tent clinical benefit. A better understanding of this apparent dis-
crepancy lies in appreciating the factors that affect impedance in DBS
and the effects of DBS stimulation on tissues. The effects and side-
effects of DBS result from the volume of tissue activated, which is
directly related to current density.4 The most widely used IPGs employ
constant voltage stimulation.4 A higher impedance results in a smaller
volume of tissue activation while a smaller impedance results in a
larger volume of tissue activation.2,6 In this case, the higher therapeutic
impedance indicates a smaller volume of tissue activation that achieved
the desired clinical effect while avoiding side effects.
In light of this information and the normal LII, it was decided to
continue using the programming settings with the best clinical response
regardless of the therapeutic impedance values.














2 months 2 3 0.8 90 180 0.186 High (.4000)
2 months 2 3 1 90 135 0.237 High
3 months 2 3 1 90 135 0.183 High
4 months 2 3 1.2 90 150 0.222 High
4 months 2 3 1.4 60 180 N/A High
5 months 2 3 1.8 60 180 0.458 High
7 months 2 3 1.9 60 135 0.622 3154
Lead integrity impedance C-0, 1317; C-1, 1342; C-2, 1348; C-3, 1391; 0-1, 2518; 0-2, 2813; 0-3, 2870; 1-2, 2728;
1-3, 2891; 2-3, 2667
Abbreviations: Vim, Thalamic Ventralis Intermedius.
Initial lead integrity impedances are summarized in the last row.
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Gaps in knowledge
Despite the wide use of DBS, multiple accepted practice guidelines
are based on limited evidence or are the basis of current active debate.
In the following sections, we will review the evidence for two uses of
impedance measurements in DBS: hardware malfunction (open and
short circuits) and mode of stimulation (constant voltage versus
constant current).
Short circuits and open circuits in DBS
Short circuits are characterized by low impedances (usually less than
50 ohms) and high currents, and open circuits by high impedances and
low currents. These can occur because of malfunction of any of the
different components of the DBS hardware (Figure 2). The symptoms
of such a malfunction typically include an acute decrease in benefit
from DBS, though it can develop gradually mimicking a ‘‘progression’’
of the underlying disorder.7
Short circuits result from either infiltration of fluids into the con-
nections or lead ‘‘fracture’’.7 The rate of occurrence has been esti-
mated to be approximately 2.5% per year.7 Open circuits can result
from lead ‘‘fractures’’ and are estimated to occur in 5% of patients and
1.8% of implanted leads.1,8 Many of these fractures are ‘‘macroscopic’’
and can be readily identified by either direct palpation or radiological
evaluation (X-rays and/or computed tomography scans). Sometimes
open circuits are noted but there is no evidence of macroscopic
abnormalities (14.3–25% of all cases).3 Limited information is available
regarding cases with a more gradual change in impedances9 or in cases
with intermittent connectivity problems.10 There are no clear guide-
lines to manage cases of open and/or closed circuits, most of the
published literature is based on case series.3 Any surgical revision is
associated with increased morbidity and mortality and thus developing
management guidelines is important. Yang et al.3 and Allert et al.10
recently proposed similar guidelines to approach cases of open circuits
(as well as a limited approach to short circuits). After ruling out the
presence of macroscopically noted problems, they recommend
attempting to reprogram with alternate usable contacts (if possible)
as well as with medication changes. If this conservative approach fails,
then they recommend intraoperative impedance and system connection
check to try to localize the problem. If localization fails by intra-
operative testing, they recommend a sequential replacement and intra-
operative impedance assessment starting with the IPG and moving
proximal to the lead until the source of the open circuit is identified.
In some cases, extraction of the entire system is required. These
proposed guidelines3,10 rely on single-center experiences and have
not been prospectively evaluated for clinical outcomes, side effects,
or cost–benefit analysis.
Constant voltage versus constant current
Current density alters the volume of tissue activated, inducing the
effects and side effects of DBS. The most widely used IPGs use
constant voltage stimulation resulting in a change of current density
with changes in impedance. LII varies over time: a gradual increase in
impedance in the first 1–3 weeks following implantation and then a
slower plateau over the next few months.11,12 In the chronic phase
(more than 6 months to 1 year) the LII tends to decrease gradually
(rate varies significantly between studies but is less than 100 ohms a
year).12–14 The mechanism of decrease in LII chronically has not been
elucidated with a possible role of brain atrophy.13,14
Impedance is determined by the effect of multiple factors: IPG and
lead connection; the surface area of the electrode(s); the characteristics
of the encapsulation layer; and the conductivity of the stimulated
tissue.2,4 The first two factors are relatively stable while the last two
are more variable. Studies have shown that the encapsulation layer
characteristics and tissue conductivity account for most of the
impedance variability.2,15 The thickness and conductivity of this
encapsulation layer is variable between individuals and is affected by
stimulation.2,5,14 Studies have shown that active contacts have lower
impedances than inactive ones.2 Determining the conductivity of
Figure 2. Schematic Representation of the Components of the Deep Brain Stimulation Hardware. From left to right, the implantable and
programmable generator (IPG), the IPG connector block (A) by which the connection cable (B) connects to the IPG. The connection cable then connects to the
electrode or lead.
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the stimulated tissue is complex. There are conductivity differences
between white and gray matter. The mean conductivity values have
not been assessed following chronic DBS stimulation.2,5 Satzer et al.5
correlated contact location (using 7 T magnetic resonance imaging and
microelectrode recording) with changes in electrode impedance in
62 patients with DBS in the subthalamic nucleus for Parkinson’s
disease. Lower impedances were noted in contacts located in the
rostral subthalamic nucleus (consistent with previous reports).14
Unexpectedly, gray matter impedances were higher than those
measured at the border of the subthalamic nucleus (as determined
by microelectrode recording and not imaging).5 Further studies will be
needed to determine the changes in the encapsulation layer and tissue
conductivity and to assess longitudinally the intra- and interindividual
variability with chronic stimulation.
Newer IPGs capable of constant current stimulation are currently
marketed to address this variability in impedance. These systems offer
a constant current density by automatically adjusting the voltage
to changes in the impedance. The field of DBS in general seems to
be moving toward more widespread adoption of the constant cur-
rent stimulation paradigm.4 Recent studies determined that constant
current stimulation is at least non-inferior to constant voltage
stimulation.4,6,16,17 The arguments in favor of adoption include a
stable current density delivery, safety, and equal effectiveness when
compared with constant voltage stimulation. Preda et al.6 and Lettieri
et al.15 studies hinted at a possible increased benefit in dystonia
patients. Larger randomized studies assessing different DBS targets in
various disease states will be required to determine the benefits of
constant current versus constant voltage stimulation.
Expert commentary
This case highlights the need for clinicians managing DBS
devices to better understand fundamental differences between the
impedance that is measured to verify lead integrity versus the
therapeutic impedance, which is measured at the active contact of
stimulation. While the former guides a clinician in assessing the
‘‘health’’ of the electrical system, the latter provides information on
the volume of brain tissue activated. The latter measure has also
been suggested as an important measure to understand the clinical
impact of DBS. The author points out the need for a methodical
approach to treating hardware malfunction. This approach should
include accurately assessing the origin of the issue, but the approach
should also include a framework for troubleshooting problems
that are more complex. Often in DBS cases, more than one issue
emerges during programming and this can be confusing to an
inexperienced programmer. Working through each issue one at a
time is important for success; however, assessing the integrity of the
DBS system is the first step to any troubleshooting algorithm.
Impedance measurements may become more important to the field
as we begin to examine questions regarding the use of constant
current stimulation. Use of constant current technology stabilizes
the amount of electrical current delivered despite impedance vari-
ability and this facilitates a smoother delivery of the electrical current.
It is unknown whether the theoretical benefits of providing a more
stable volume of tissue activation will translate into a meaningfully
different outcome.
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